ijms-logo

Journal Browser

Journal Browser

Using Model Organisms to Study Complex Human Diseases—2nd Edition

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: 20 September 2026 | Viewed by 830

Special Issue Editor


E-Mail Website
Guest Editor
Istituto di Biologia e Patologia Molecolari del Consiglio Nazionale delle Ricerche (IBPM-CNR), Dipartimento di Biologia e Biotecnologie, Università Sapienza di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy
Interests: chromatin structure and function; cell division and cytokinesis; DNA repair; cancer epigenetics; artificial intelligence and cancer physiopathology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

A model organism is a living species that allows for the study of specific biological problems, and the discoveries may be applied—with a limited number of adjustments—to a wide range of other species. To be defined as a “model”, an organism should also possess additional properties, such as being relatively simple, having the possibility to be established in a number of laboratories, having rapid generation times and a relatively low rearing cost, having stable and easy to recognize phenotypes, allowing to be studied at the “-omics” level, and having the availability of specific tool to study the modification of gene expression, to perform loss- and gain-of-function experiments. Classical model organisms include both prokaryotes (the bacterium Escherichia coli) and eukaryotes, either unicellular (the budding yeast Saccharomyces cerevisiae, the fission yeast Schizosaccharomyces pombe, or the numerous human cell cultures used worldwide, especially in cancer research) or multicellular, such as the roundworm Caenorhabditis elegans, the fruit fly Drosophila melanogaster, the zebrafish Danio rerio, the plant Arabidopsis thaliana, the African clawed frog Xenopus laevis, the rat Rattus norvegicus and the mouse Mus musculus. Additional models have been developed over time, which are also quite distant from each other on an evolutionary scale to overcome the limitations of working on a simplified model, as correctly noted by Bertile and coworkers in a recent paper (https://doi.org/10.1038/s42003-023-05458-x).

The main aim of studying model organisms is, in most instances, to have a better understanding of human pathologies and unveil potential therapeutic targets. The conservation of basic cellular functions, such as DNA replication and repair, transcription and translation, post-transcriptional regulation, epigenetics and physiology, makes these organisms amenable for studying human disease.

The aim of this Special Issue is to collect the most up-to-date research showing the use of model organisms to study human conditions. We welcome the submission of original research articles and reviews in this field, employing both classical and non-classical models, as well as all contributions which provide novel insights into how these models have contributed to our understanding of the etiology of and therapeutic approaches to human pathology.

Dr. Roberto Piergentili
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • model organism
  • Escherichia coli
  • yeast
  • Caenorhabditis elegans
  • Drosophila melanogaster
  • zebrafish
  • Arabidopsis thaliana
  • Xenopus laevis
  • rat and mouse model
  • human disease
  • inherited disease
  • cancer
  • rare disease
  • genetics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

27 pages, 2495 KB  
Article
The Stimulating Effect of Low-Molecular-Weight Luteinizing Hormone Receptor Agonist on Steroidogenesis and Ovulation in Female Rats with Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome
by Kira V. Derkach, Alena S. Pechalnova, Inna I. Zorina, Irina Yu. Morina, Liubov V. Bayunova, Irina V. Romanova, Irina V. Fedorchuk, Julian R. Ryzhov, Elizaveta E. Chernenko, Viktor N. Sorokoumov and Alexander O. Shpakov
Int. J. Mol. Sci. 2026, 27(6), 2748; https://doi.org/10.3390/ijms27062748 - 18 Mar 2026
Viewed by 503
Abstract
Polycystic ovary syndrome (PCOS) is associated with impaired ovarian steroidogenesis and ovulation, which necessitates the development of effective ovulation inducers for PCOS. The aim of the study was to evaluate the effects of allosteric luteinizing hormone receptor agonist TP03 and human chorionic gonadotropin [...] Read more.
Polycystic ovary syndrome (PCOS) is associated with impaired ovarian steroidogenesis and ovulation, which necessitates the development of effective ovulation inducers for PCOS. The aim of the study was to evaluate the effects of allosteric luteinizing hormone receptor agonist TP03 and human chorionic gonadotropin (hCG) on ovarian steroidogenesis, as well as ovulation in prepubertal female rats with dehydroepiandrosterone(DHEA)-induced PCOS. Taking into account differences in progesterone levels, cohorts with high (PCOS(H)) and low (PCOS(L)) progesterone were formed and treated with Follimag and Cetrotide. After 48 h, TP03 (25 mg/kg) or hCG (25 IU/rat) were injected, and hormone levels, gene expression, and ovarian morphology were assessed. The PCOS(H)-cohort exhibited irregular estrous cycles, ovarian cysts, and increased ovarian mass and estradiol levels, but the number of corpora lutea (CL) was maintained. In the PCOS(L)-cohort, ovarian weight was increased, and Star, Cyp11a1, and Adamts1 gene expression as well as the CL number were decreased. In both cohorts, TP03 and hCG increased progesterone levels and the expression of steroidogenesis (Star, Cyp11a1) and ovulation (Cox2, Adamts1, Egr1) genes, as well as inducing CL formation. Thus, TP03, like hCG, stimulates steroidogenesis and ovulation in PCOS-rats with different progesterone levels, which provides the first evidence of the effectiveness of allosteric LHR agonists as ovulation triggers in PCOS. Full article
(This article belongs to the Special Issue Using Model Organisms to Study Complex Human Diseases—2nd Edition)
Show Figures

Figure 1

Back to TopTop